Podcast
Questions and Answers
Which injection site is recommended for newborns receiving nirsevimab?
Which injection site is recommended for newborns receiving nirsevimab?
- Anterolateral thigh muscle (correct)
- Ventrogluteal site
- Deltoid muscle of arm
- Gluteus maximus
What is the recommended needle length for infants aged 1-12 months?
What is the recommended needle length for infants aged 1-12 months?
- 1" (correct)
- 2"
- 5/8"
- 1-1/4"
Which of the following is NOT one of the 7 rights to affirm at the time of administration?
Which of the following is NOT one of the 7 rights to affirm at the time of administration?
- Right immunization
- Right patient
- Right needle gauge (correct)
- Right documentation
What is the maximum recommended volume for intramuscular injections in the anterolateral thigh muscle for infants?
What is the maximum recommended volume for intramuscular injections in the anterolateral thigh muscle for infants?
Which age group would typically receive an injection volume on the higher end of the scale?
Which age group would typically receive an injection volume on the higher end of the scale?
Which of the following strategies might healthcare providers utilize to minimize injection volume?
Which of the following strategies might healthcare providers utilize to minimize injection volume?
For which of the following vaccines is it recommended to use an alternate route other than intramuscular administration?
For which of the following vaccines is it recommended to use an alternate route other than intramuscular administration?
What is the recommended needle gauge for intramuscular injections of nirsevimab?
What is the recommended needle gauge for intramuscular injections of nirsevimab?
Which needle length is appropriate for IM injection in toddlers and children weighing less than 130 lbs?
Which needle length is appropriate for IM injection in toddlers and children weighing less than 130 lbs?
What is the first right to affirm at the time of immunization administration?
What is the first right to affirm at the time of immunization administration?
Under what condition is nirsevimab not recommended for patients under 8 months of age?
Under what condition is nirsevimab not recommended for patients under 8 months of age?
What is the appropriate dosage of nirsevimab for a patient weighing more than 5 kg?
What is the appropriate dosage of nirsevimab for a patient weighing more than 5 kg?
Which of the following groups is newly recommended to receive nirsevimab second-season prophylaxis?
Which of the following groups is newly recommended to receive nirsevimab second-season prophylaxis?
What indicates that nirsevimab should be generally recommended for a patient 8-19 months old?
What indicates that nirsevimab should be generally recommended for a patient 8-19 months old?
Which right relates to ensuring correct documentation during immunization administration?
Which right relates to ensuring correct documentation during immunization administration?
What condition must be true for children who are severely immunocompromised to receive nirsevimab?
What condition must be true for children who are severely immunocompromised to receive nirsevimab?
Flashcards
Nirsevimab administration
Nirsevimab administration
Administration of Nirsevimab (Beyfortus) for prevention of Respiratory Syncytial Virus (RSV).
7 Rights of Immunization
7 Rights of Immunization
Crucial principles to minimize errors during immunization, encompassing the patient, time, immunization type, dose, route, site, and documentation.
Intramuscular (IM) injection sites
Intramuscular (IM) injection sites
Specific anatomical locations for IM injections, varying by age and body size, with options like anterolateral thigh or deltoid.
Needle Length (IM)
Needle Length (IM)
Signup and view all the flashcards
Co-administration of vaccines
Co-administration of vaccines
Signup and view all the flashcards
Injection volume (Deltoid)
Injection volume (Deltoid)
Signup and view all the flashcards
Injection volume (Thigh)
Injection volume (Thigh)
Signup and view all the flashcards
Alternative routes (other than IM)
Alternative routes (other than IM)
Signup and view all the flashcards
Needle length for IM deltoid injection (toddlers, children, <130 lbs)
Needle length for IM deltoid injection (toddlers, children, <130 lbs)
Signup and view all the flashcards
Needle length for IM thigh injection (adults)
Needle length for IM thigh injection (adults)
Signup and view all the flashcards
7 rights of immunization administration
7 rights of immunization administration
Signup and view all the flashcards
Nirsevimab administration eligibility (under 8 months)
Nirsevimab administration eligibility (under 8 months)
Signup and view all the flashcards
Nirsevimab administration eligibility (mother's RSV vaccine during pregnancy)
Nirsevimab administration eligibility (mother's RSV vaccine during pregnancy)
Signup and view all the flashcards
Nirsevimab administration eligibility (previous dose in current season)
Nirsevimab administration eligibility (previous dose in current season)
Signup and view all the flashcards
Nirsevimab dosage (8-19 months)
Nirsevimab dosage (8-19 months)
Signup and view all the flashcards
Nirsevimab dosage (<5kg)
Nirsevimab dosage (<5kg)
Signup and view all the flashcards
Study Notes
RSV Vaccine (Beyfortus/Nirsevimab)
- Vaccine is for Respiratory Syncytial Virus (RSV)
- Administration guidelines provided
- Follow 7 rights of administration: patient, time (age, RSV season), immunization, dosage (weight-based), route/needle/technique, site, documentation.
Injection Technique
- Use 22-25 gauge needle
- Needle length varies by age and body mass
- Newborns (0-28 days): 5/8" needle, anterolateral thigh
- Infants (1-12 months): 1" needle, anterolateral thigh
- Toddlers (1-2 years): 1-1/4" or 5/8"-1" needle, deltoid muscle.
- Alternative needle lengths may be used based on skin tension
- %" needle for toddlers/children/patients < 130 lbs in deltoid muscle
- 1" needle for thigh muscle for adults
- Average volumes for injection
- Deltoid (arm): 0.5 mL (range 0.5-2 mL)
- Anterolateral thigh: 1-4 mL (range 1-5 mL)
Co-administration
- Simultaneous administration with other age-appropriate vaccines is recommended
- CDC creating job aid to address volume issues related to multiple injections.
Patient Risk Factors for Nirsevimab
- Age: Infants under 8 months are not recommended for the vaccine
- Infants 8-19 month who meet high-risk criteria are recommended.
- High Risk Criteria (8-19 months):
- Chronic lung disease of prematurity (requiring medical support) in the 6 months prior to the RSV season.
- Severe immunocompromised conditions
- Cystic fibrosis with severe lung disease (hospitalization, imaging abnormalities) or weight-for-length <10th percentile
- American Indian and Alaska Native children (for second-season prophylaxis)
- Other Considerations:
- Maternal RSV vaccine during pregnancy
- Infant born within 14 days of maternal vaccination
- Previous dose of nirsevimab in the RSV season
- Consideration of nirsevimab when the potential benefit outweighs the risks for certain rare situations
- Patients should be weighed prior to administration. Dosages vary according to weight.
Other Vaccine Information
- Include age-appropriate combination vaccines (Pentacel, Pediarix, Vaxelis).
- Alternate routes (subcutaneous) are an option for some vaccines (IPV, MMR, Varicella, PPSV23)
- Take advantage of recommended age ranges for other vaccines (e.g., 3rd HepB dose at 18 months)
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz provides essential information on the administration guidelines for the RSV vaccine, Beyfortus (Nirsevimab). It covers the seven rights of administration, appropriate injection techniques based on age, and co-administration with other vaccines. Test your knowledge on how to safely and effectively administer this vaccine.
